Alina Amalia H.
- Country
- Romania
- Department
- Medical Oncology
Research Overview
- Phase 3 Randomized Study of Pembrolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in HR+/HER2- Metastatic Breast Cancer
- Phase III Randomized Study of Lurbinectedin Alone or with Irinotecan Versus Topotecan or Irinotecan in Relapsed Small Cell Lung Cancer Patients
- A Phase III, multisite, double-blinded randomized trial of BNT327 in combination with chemotherapy (etoposide/carboplatin) compared to atezolizumab in combination with chemotherapy (etoposide/carboplatin) in participants with first-line extensive-stage small-cell lung cancer
Data & Insights
Has run more than one trial at 35 of 189 partner sites.
Specializations
Lung Cancer Research
This investigator specializes in treating small cell lung cancer (SCLC), with particular emphasis on developing therapeutic strategies for patients who have experienced relapse after initial platinum-based treatments.
- Advanced SCLC Management
- Relapsed Disease Treatment
- Novel Therapeutic Combinations
The investigator focuses on evaluating innovative treatment approaches including single-agent and combination therapies for resistant cases.
Breast Cancer Expertise
The investigator demonstrates significant expertise in treating hormone receptor-positive (HR+) and HER2-negative breast cancer, particularly focusing on advanced stages of the disease.
- Metastatic Breast Cancer Treatment
- Immunotherapy Applications
- Chemotherapy Combinations
Their research encompasses novel therapeutic approaches for locally recurrent inoperable and metastatic breast cancer cases.
Therapeutic Innovation
The investigator explores innovative treatment modalities across multiple cancer types, with particular attention to combining established and emerging therapies.
- Immunotherapy Integration
- Biomarker-Driven Treatment
- Advanced Disease Management
Their work includes evaluation of targeted therapies and their integration with conventional treatment approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.